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Abstract: Novel, non-invasive wearable laser Doppler flowmetry (LDF) devices measure real-time
blood circulation of the left middle fingertip and the topside of the wrist of the left hand. The LDF
signals are simultaneously recorded for fingertip and wrist. The amplitude of blood flow signals
and wavelet analysis of the signal are used for the analysis of blood perfusion parameters. The aim
of this pilot study is to validate the accuracy of blood circulation measurements recorded by one
such non-invasive wearable LDF device for healthy young non-smokers and smokers. This study
reveals a higher level of blood perfusion in the non-smoker group compared to the smoker group and
vice-versa for the variation of pulse frequency. This result can be useful to assess the sensitivity of the
wearable LDF sensor in determining the effect of nicotine for smokers as compared to non-smokers
and also the blood microcirculation in smokers with different pathologies.
Keywords: wearable laser Doppler flowmetry; blood perfusion; wavelet analysis; smokers
1. Introduction
Tobacco smoking is a major single cause of global cancer deaths and has been labelled as the
biggest risk factor for premature deaths in industrialised countries such as the UK [1–3]. It is well
known that tobacco smoking directly affects the cardiovascular system [4] through several mechanisms
such as atherosclerosis, development of ischemic heart disease, and peripheral artery disease and when
combined with other risk factors such as hyperlipidaemia, hypertension and obesity [5]. Nicotine
and carbon monoxide, two major constituent chemicals in cigarettes, interfere with the ability of the
cardiovascular system to function normally. Exposure to nicotine and carbon monoxide change the
heart and blood vessels in ways that increase the risk of heart and cardiovascular disease [5,6]. Nicotine
causes human blood vessels to constrict [6], which limits the amount of blood that flows to human
organs. It is well known that the blood is the most important connective tissue in the human body that
is primarily responsible for the distribution of nutrients and oxygen and the removal of carbon dioxide
and metabolic waste products from organs. Any deviation in normal blood circulation, such as over or
underflow may indicate a major systemic abnormality. Thus, as an effect of smoking, the constant
constriction in the blood vessels results in stiff and non-elastic blood vessels. To compensate for this,
the heart starts pumping more blood around the body resulting in its enlargement and increased heart
rate [7]. This increased rate, an enlarged heart, and stiffer blood vessels make it harder to pump the
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blood and provide the body with the required amount of oxygen and nutrients [6]. These structural
changes in the blood vessels and heart increase the risk of high blood pressure and cardiovascular
disease, ultimately leading to higher mortality and morbidity among the smoking population bringing
significant financial burdens on the National Health System and the economy [8,9].
Continuous monitoring of human health and activity using wireless wearable devices will be
a key technology in the ubiquitous sensor network society for years to come. Recent advances in
the development of the latest-generation of watch-size wearable devices based on ultra-compact
semiconductor lasers have opened a new perspective for the implementation of compact blood flow
monitoring sensor systems for personalised medicine [10,11]. This wearable device is based on laser
Doppler flowmetry (LDF), which is closely related to the dynamic light scattering approach [12].
This technology is widely used for non-invasive measurements in living tissue optical parameters.
These devices use a single-mode fibre coupled near-infrared (NIR) laser irradiation which is scattered
and reflected from moving red blood cells (RBCs) [10]. Thereafter, these RBC movements generate the
frequency-shifted scattering of the initial illumination which is detected by one or two photodetectors
with the appropriate signal processing of both photocurrents (initial and reflected). This allows for
the subsequent evaluation of the intensity of the blood perfusion. These data are then analysed
with the Fourier approach of giving an estimation of the Doppler spectrum that means the LDF
records are proportional to the RBCs’ velocity. Thus, LDF is used for functional diagnostics of the
blood circulation system as well as significant diseases associated with cardiovascular disorders and
their complications. Furthermore, this method allows evaluation of the oscillatory processes in the
microcirculatory systems. Five rhythmic oscillations are isolated from LDF recordings with the help of
wavelet analysis; endothelial (frequency interval 0.0095–0.02 Hz), neurogenic (0.02–0.06 Hz), myogenic
(0.06–0.16 Hz), respiratory (0.16–0.4 Hz), and cardiac or pulse rhythm (0.4–1.6 Hz) [13]. Recent studies
on these wearable LDF devices have shown the high synchronisation of blood flow rhythms in the
contralateral limbs of healthy volunteers [11]. Additionally, it was reported that wearable devices
can measure the age-related changes in blood perfusion for healthy participants [10]. Although there
were quite a few numbers of articles available based on smoker’s blood microcirculation measured
by LDF [14–18], no research was conducted in understanding the comparable modulation of the
blood flow parameters in non-smoking and smoking volunteers using wearable LDF. Thus, this study
demonstrated the feasibility of the wearable device in distinguishing cardiovascular parameters
between non-smoking and smoking groups of volunteers. This preliminary research was necessary
for planning more expensive and large-scale pre-clinical trials. Within the framework of the work,
the strengths and weaknesses of the proposed LDF wearable approach were revealed. The applicability
of the sensor for participants was assessed and estimation of the size of the participant groups were
evaluated for obtaining sufficient statistical power of future studies.
2. Materials and Methods
2.1. Wearable Laser Doppler Flowmetry Monitor
The experiments were performed with two wearable LDF monitors “FET-1” (Aston Medical
Technology Ltd., http://www.amedtech.co.uk/) for recording the blood perfusion (Figure 1).
These devices consisting of three identical channels for recording blood perfusion, skin temperature,
and movements provide measurement at any desirable point of the human body. The system also
comprises a wireless data acquisition module.
Every wearable sensor in the system uses a VCSEL chip (850 nm, 1.4 mW/3.5 mA, Philips,
The Netherlands) as a single-mode laser source to implement fibre-free direct illumination of tissue.
The fibre probe movements can cause high-frequency intensity fluctuations due to speckle movement.
The intensity fluctuations can themselves produce an apparent Doppler shift [19,20] which will
highly disturb the initial data acquisition creating faulty conclusions. Fibre-free solution and direct
illumination of tissue by the laser diode make it possible to decrease these artefacts which are common
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in fibre-based LDF systems, as well as to avoid fibre coupling losses. To find a correlation between the
changes in the registered blood perfusion and actual body movements the integral accelerometer has
been embedded in the sensor.
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where PU is perfusion index, S(U1(t) −U2(t)) is power spectral density of the difference signal from
two photodetector channels, U1(t), U2(t) is the signal from the photodetector converted to voltage.
The signal is also normalised to the constant component of the photocurrent. The radiation,
scattered on moving red blood cells, and the back-reflected signal are received by two photodiodes.
Next, the current is converted on the transimpedance amplifier, and the corresponding signal
amplification is performed. The next stage of processing is low-pass filtering, constant component
extraction, and high-pass filtering. Next, the variable component is normalised to a constant to avoid
the influence of different levels of reflection under different optical conditions. The final component
is a differential amplifier that protects the circuit from common-mode interference in the signal and
reduces the impact of motion artifacts. In general, the presented wearable devices have an identical
electronic circuit with stationary LDF devices [13,21,22] and allow the registration of the same signals.
2.2. Study Design
This pilot study was conducted in accordance with the principles set out in the Helsinki Declaration
of 2013 by the World Medical Association and was approved by the human ethics committee of Aston
University, Birmingham, UK (Ethics approval #1685). This pilot-study involved nine healthy volunteers
without pre-existing cardiovascular and other chronic medical conditions who are divided into
two groups: non-smokers and smokers. The average age of the non-smoker group was 34.2 ± 3.8 years
and the smoker group was 38± 4.7 years. Two females and three males were included in the non-smoker
group and smoker group consisted of 1 female and 3 males for this pilot study. None of the participants
had a history of cardiovascular disease (CVD) or other illness and they were not under any medications.
After being informed and explained the study design, every volunteer provided written consent and
filled a questionnaire to detail their current health conditions. A short history for the volunteers
including medication history, alcohol consumption for the last 24 hours, history of exercise (such as
cycling, treadmill, jogging), and a detailed history of smoking were taken.
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2.3. Testing Procedure
Blood perfusion parameters were collected in a sitting position, in a state of physical and mental
rest (avoid reading, writing, and talking). The hand of the volunteers was placed on a table at the
heart’s level and they were requested not to ingest any caffeine and alcohol-containing drinks at
least one hour and twelve hours prior to allocated measurements time, respectively. The index of
blood perfusion was recorded for 8 minutes, while the sensors were attached to the surface of the left
middle fingertip and the topside of the left wrist without applying any pressure on the study area.
The fingertip was chosen because it is rich in arteriolar venular anastomoses (AVA), whereas the wrist
is known to contain less AVA. The measurement was taken twice a day: morning (around 11.00) and
evening (around 18.00) for any 5 days in consecutive two weeks.
2.4. Data Proccesing and Analysis
Specialised software was developed to work with the system. This allowed for real-time control of
the course of the experiment and analysis of the recorded parameters. Figure 2 depicts an example of
the displayed parameters which show the raw data of blood perfusion, temperature, and the movement
for the fingertip and wrist in Figure 2a. After acquiring the data, the oscillation rhythms of each
measurement were analysed using the built-in module “wavelet analysis” [23] which is displayed
in Figure 2b. This wavelet analysis determines the maximum amplitude of blood perfusion and
corresponding data for each of the five oscillations mentioned in the previous section.
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In short, the LDF signal was d composed using a wavel t tra sform as:
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where x(t) is a target signal, τ is local time index, s is scaling factor, * means complex conjugation.
The Morlet wavelet defined in the form
ψ(t) = e2πite−t
2/σ (3)
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was used with the decay parameter σ = 1. This wavelet allows one to ensure sufficient time-frequency
resolution and is well localized in the time domain.
Figure 2 shows that the forearm region has smaller variations of the LDF signal, and spectral
analysis shows pronounced peaks in the cardiac, myogenic, neurogenic, and endothelial ranges.
We excluded respiratory fluctuations from further statistical analysis due to the lack of pronounced
peaks, which may be due to recording signals in basal conditions without any functional tests [27,28].
Taking into account the relatively small sample sizes, nonparametric methods were used to
confirm the reliability of differences in the results, namely the Mann–Whitney U-test. Values of p < 0.01
were considered significant. Based on the results of this pilot study, we have performed sample size
estimations for minimisation of type two error in future studies:
n = 2SD2
(Zα/2 + Zβ)
2
d2
, (4)
where is the SD is standard deviation; Zα/2 = 1.96 at type 1 error of 5%; Zβ = 0.84 at 80% power; d is the
difference between mean values [29].
3. Results
Figure 3a, b shows the blood perfusion for all the individual participants including non-smokers
and smokers at palmer skin of the left middle finger and left wrist, recorded in morning and evening
sessions. It does not show any noticeable difference between non-smokers and smokers. After averaging
for all non-smokers and smokers, the study reveals a higher level of perfusion in the non-smoker group
as compared to the smoker group, showed in Figure 3c,d.
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The results depicted in Figures 4 and 5 reveal the comparisons of the wavelet analysis parameters
on the fingertip and wrist for both subject groups. The variations of the amplitude of the endothelial
(Ae), neurogenic (An), myogenic (Am), and pulse (Ap) are shown in Figure 4a,b for fingertip and wrist
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respectively. Amplitude measurements on the fingertip are consistently higher for the non-smoker
group as compared to the smoker group for all oscillations at both morning and afternoon sessions.
However, data received from the wrist does not show any conclusive variations between non-smoker
and smoker groups. This is possibly due to the lower number of AVAs in the wrist area resulting in a
lack of conclusive information. In addition, pulse amplitude data taken from both fingertip and wrist
exhibits a decrease for the smoker group at both morning and afternoon sessions.Biosensors 2020, 10, x 6 of 10 
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In Figure 5, the maximum peak frequencies are observed for endothelial, neurogenic, myogenic
and pulse rhythms. The oscillation frequency varies for the smokers as compared to non-smokers,
shown in Figure 5. It is clearly demonstrated that the pulse frequency is higher for the smoker
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group as compared to the non-smoker group at both morning and afternoon sessions for fingertip.
Additionally, the wrist shows the same pattern for the morning session. This indicates that smoking
raises blood pressure and increases the heart rate for smokers, which is confirmed in Figure 5a. For other
oscillations, the frequency shows higher value for smoker than non-smoker’s fingertip at both morning
and afternoon sessions, however, it is slightly different for wrist position.
4. Discussion
Here, we presented a pilot study to assess the feasibility of the wearable device in differentiating
cardiovascular parameters between non-smoking and smoking groups of volunteers. Due to the small
sample size, statistical analysis did not show significant differences, but the results show clear trends
for differences in the measured and calculated parameters.
Lower blood perfusion for the smokers was observed compared to non-smokers in Figure 3c,d.
This is probably due to the effect of nicotine, a major constituent of cigarette smoke. Nicotine constricts
the blood vessels as well as those in the skin and coronary blood vessels. This vasoconstriction of the
skin results in reduced cutaneous blood flow.
The amplitude of endothelial mechanism reduces for the smokers at fingertips, evidenced in
Figure 4a. It is known that endothelial cells inside of the blood and heart vessels help to regulate
blood clotting and vascular relaxation. These cells generally synthesize and release nitric oxide (NO)
which dilate the blood vessels of the body. However, nicotine induces the chance to increase the
endothelial dysfunction which is known to cause vasoconstricting substances and narrows the blood
vessels [30]. As a consequence, the blood perfusion reduces for the smoker group, evidenced in
Figure 3c,d. The plots for fingertip and wrist both show a decrease in amplitude of the neurogenic
oscillation for smokers. This is an indicator of higher neurogenic resistance and possible decreased
blood flow in the arterioles for the smoker group, which was noticed in the blood perfusion plot
of Figure 3c [13]. The source of myogenic oscillation is representative of the spontaneous activity
of smooth muscle cells that is associated with the regulation of blood pressure of the human body.
Nicotine increases blood pressure for smokers and consequently increases the tension of the vascular
wall resulting in the contraction of the vascular smooth muscle. The amplitude of myogenic oscillation
decreases for smokers as shown in Figure 4a. Measurements from the wrist show a similar amplitude
pattern in myogenic rhythm.
The pulse frequency was higher for the smokers as shown in Figure 5 because the cigarette
smoking increases the cardiac work by stimulating the heart rate approximately 10–15 bpm and the
blood pressure (acute increase 5–10 mm Hg) [31]. It was already discussed that nicotine constricts
the blood vessels, but it can also increase coronary blood flow by increasing the cardiac output,
causing subsequent flow-mediated dilation (FMD). It means that the heart needs to pump more due
to constriction of the blood vessels that increases the cardiac output as well as heart rate which was
evidenced in Figure 5. In addition, the prolonged exposure of carbon monoxide from a cigarette can
increase carboxyhemoglobin concentration to as high as 10% for the heavy smoker and may induce
anaemia as it binds more readily to haemoglobin than oxygen. As a result, it blocks oxygen-binding
sites and impairs the release of the oxygen that is able to bind. Carbon monoxide induced hypoxemia
enhances the chance of smoking-related thrombogenesis via increased blood viscosity as the body
compensates it by increasing red blood cell mass.
Overall, the current study showed that the wearable device (FET-1) is capable of differentiating
cardiovascular parameters between non-smokers and smokers. Our promising results demonstrate the
robustness of both the data acquisition and the spectral analysis methods employed to characterise
measured optical data. However, it is necessary to continue research in a broader way with a larger
sample size to provide a clinical and statistically significant difference in blood perfusion parameters
between non-smokers and smokers.
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5. Study Limitations and Future Directions
It is shown that most of our results should be considered as preliminary estimates because the
research has some limitations. The future work will focus on overcoming the limitations described below.
The number of studied subjects in this research was relatively small. High parameters divergence
together with low difference leads to low robustness of the results. Spectral characteristics of LDF
samples are characterised by high intra-subject variability. Our estimations have shown that the
sample size should be estimated in at least 80 subjects in every group under consideration to minimize
type II error.
This work had sufficient limitations due to the LDF sample length, which led to inaccurate
interpretation on low frequency oscillations. For reliable statistics, one should ideally include 10 cycles
for each of the frequencies under investigation. We had an 8 min recording, which was why the reliable
results can be obtained only for frequencies higher than 0.02 Hz. For lower frequencies, the results
presented demonstrate only the tendency towards to quantitative data.
6. Conclusions
The present pilot-study demonstrated that the applied wearable device (FET-1) is capable
of differentiating cardiovascular parameters between non-smokers and smokers. It presents the
results of blood perfusion measurements with the rhythmic oscillations using wearable VCSEL-based
sensor system. Studies have shown a comparatively low blood flow for smoker volunteers than the
non-smokers. This LDF based wearable sensor system has several advantages which open excellent
prospects for a new type of experiments. Power-efficient VCSEL-based devices perform the long-term
blood perfusion monitoring which is completely non-invasive. Experiments have shown that the
introduction of wireless wearable devices for recording blood microcirculation is a convenient solution
for use in medical diagnostics. The wearable implementation of LDF has a high potential in the field of
monitoring cardiovascular diseases and is also of great interest for the diagnosis of other conditions
associated with microvascular disorders. Portability and low sensitivity to motion artefacts make them
mobile and suitable for home use. Furthermore, the sensor device demonstrates the spectral analysis of
LDF signal using wavelet transformation to evaluate the regulatory mechanisms and to distinguish the
difference between non-smokers and smokers. The presented pilot study of the wearable VCSEL-based
LDF sensors provides early results that will need further validation with larger clinical studies.
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